Massive study tracks 2500 kids from womb to uncover allergy roots
NCT ID NCT04798079
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study enrolls 2500 pregnant women and follows their children from before birth up to age 3 (or 6 for those who continue). Researchers collect biosamples and environmental data to identify early-life markers and biological pathways that lead to food allergy and atopic dermatitis (eczema). The goal is to understand why some children develop these allergic conditions, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could reveal early-life markers and biological pathways that predict food allergy and eczema, pointing toward future prevention strategies.
What could go wrong
This is an observational study, not testing a treatment. It may not identify clear risk markers, and findings may not lead to direct interventions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arkansas Children's Hospital
Little Rock, Arkansas, 72202, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Henry Ford Health System, Division of Allergy and Immunology
Detroit, Michigan, 48202, United States
-
Johns Hopkins Children's Center, Department of Allergy & Immunology
Baltimore, Maryland, 21287, United States
-
Kravis Children's Hospital, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Massachusetts General Hospital, Translational and Clinical Research Center
Boston, Massachusetts, 02114, United States
-
National Jewish Health
Denver, Colorado, 80206, United States
-
North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology
Chapel Hill, North Carolina, 27599, United States
-
Northwestern University Feinberg School of Medicine: Dept of Dermatology
Chicago, Illinois, 60611, United States
-
Sean N. Parker Center for Allergy & Asthma Research at Stanford University
Stanford, California, 94040, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States
-
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin, 53792, United States
-
Vanderbilt University Medical Center Department of Pediatrics Division of Pediatric Allergy, Immunology, and Pulmonary Medicine
Nashville, Tennessee, 37232, United States